Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.

PLoS One · 2010 · PMC2935387 · PMID 20838641

Europe PMC DOI

hedged sentence

0.1380

closest p · 2.8× alpha

0.1380

boldest claim

The sentences

did not reach statistical significancep = 0.138not close (p > 0.1)

The risk of rash in those on NVP was increased five-fold among those with CD4 percent >20%, though this finding did not reach statistical significance (NVP - 4/79 (5.1%), non-NVP-2/178 (1.1%) p = 0.138, RR = 4.51 (0.84–24.1)).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.